Is It Time To Reassess Apellis Pharmaceuticals (APLS) After The Recent Share Price Slide
- If you are trying to work out whether Apellis Pharmaceuticals is attractively priced or not, the recent share price and valuation checks give you a lot to think about.
- The stock last closed at US$22.58, with returns of a 3.2% decline over 7 days, 17.3% decline over 30 days, 12.7% decline year to date, 20.9% decline over 1 year, 56.3% decline over 3 years and 49.5% decline over 5 years.
- Recent news around Apellis has kept attention on how the market is reassessing risks and opportunities for the business. Headlines have focused on ongoing developments in its pipeline and commercial progress, which helps frame how investors are thinking about these share price moves.
- Apellis currently has a valuation score of 2 out of 6. In this article…
Source link
